Beijing Konruns Pharmaceutical Co.,Ltd. reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was CNY 587.99 million compared to CNY 596.6 million a year ago. Revenue was CNY 587.99 million compared to CNY 596.6 million a year ago.

Net income was CNY 103.67 million compared to CNY 137.22 million a year ago. Basic earnings per share from continuing operations was CNY 0.6625 compared to CNY 0.8703 a year ago. Diluted earnings per share from continuing operations was CNY 0.6625 compared to CNY 0.8703 a year ago.